Report - CLINICAL STUDY PROTOCOL · 2020. 5. 2. · Neurocrine Biosciences, Inc., Study No. NBI-98854-TD4001 Clinical Protocol Amendment No. 3 Final Version . 16 April 2019 Confidential 2

Please pass captcha verification before submit form